Coccygodynia — Evidence-Based Clinical Protocol

Coccygodynia: An Evidence-Based Clinical Protocol for Diagnosis and Stepwise Management

Review and clinical protocol for orthopedic surgeons, pain medicine and rehabilitation specialists. Version: May 2026.

Summary. Coccygodynia (coccydynia, tailbone pain) is pain localized to the coccyx, typically aggravated by sitting and relieved by standing. The female-to-male ratio is approximately 5:1, with peak incidence in the fourth and fifth decades. Most cases respond to a structured stepwise conservative program; the minority require interventional or surgical management. Reliable diagnosis requires dynamic radiography (sitting/standing lateral views) and digital rectal examination; Maigne's classification then determines the optimal treatment trajectory. This protocol consolidates current evidence into a practical clinical pathway.

Table of Contents

1. Functional anatomy and clinical relevance
2. Etiology and Maigne's classification
3. Clinical evaluation and imaging
4. Differential diagnosis and red flags
5. Stage 1: Ergonomic and pharmacological management
6. Stage 2: Physiotherapy protocol
7. Stage 3: Neuropathic pain management
8. Stage 4: Interventional procedures
9. Stage 5: Surgical management
10. Special populations
11. Follow-up and escalation criteria
12. References

1. Functional Anatomy and Clinical Relevance

The coccyx consists of three to five rudimentary vertebrae (typically four) that articulate proximally with the sacrum via the sacrococcygeal joint, a fibrocartilaginous synchondrosis. Key insertions of clinical relevance include the gluteus maximus, levator ani, coccygeus muscle, and the anococcygeal ligament. The Walther ganglion (ganglion impar) — the terminal fused ganglion of the bilateral sympathetic chains — lies anterior to the sacrococcygeal junction and is the principal target for sympathetic blockade in refractory coccygodynia.

Normal sagittal mobility of the coccyx during transition from standing to sitting averages 5–25°. Mobility below 5° or above 25° is considered abnormal and correlates with symptomatic coccygodynia.

2. Etiology and Maigne's Classification

2.1. Etiological categories

• Traumatic (≈ 60–70%): falls onto the buttocks, childbirth (especially with instrumental delivery or large neonate), prolonged cycling, repetitive pressure.
• Non-traumatic: degenerative changes of the sacrococcygeal disc, idiopathic, infection (rare), tumor (rare — see red flags).
• Pelvic floor dysfunction: hypertonic levator ani / coccygeus producing referred coccygeal pain — frequently underdiagnosed.
• Postural / postpartum: prolonged sitting on hard surfaces, sedentary occupations, post-delivery state.

2.2. Maigne's radiographic classification

Based on dynamic radiography, the coccyx is categorized into four functional groups that directly inform management:

Type	Finding	Frequency	Preferred treatment direction
1	Hypermobile coccyx (flexion > 25°)	25–30%	Postural correction, manual therapy; coccygectomy if refractory
2	Posterior subluxation	15–20%	Manual reduction, injections; coccygectomy if refractory
3	Anterior subluxation	15–20%	Often associated with higher BMI; weight management, injections
4	Immobile coccyx ± bony spicule	15%	Spicule resection or partial coccygectomy
Normal mobility	5–25°, no subluxation	20–25%	Consider pelvic floor dysfunction, neuropathic pain, ganglion impar pathology

3. Clinical Evaluation and Imaging

3.1. History

• Pain quality (deep, well-localized to coccyx), aggravators (sitting on hard surfaces, transition from sit to stand), relievers (standing, sitting on one buttock, leaning forward).
• Trauma history: fall, childbirth (parity, mode of delivery, neonatal weight, instrumental assistance), cycling exposure.
• Bowel habits: constipation worsens symptoms; defecation may exacerbate pain.
• Duration: acute (< 8 weeks), subacute, chronic (> 6 months).
• Prior treatments and response.

3.2. Physical examination

• Inspection: pilonidal sinus, scars, swelling, midline cleft abnormalities.
• External palpation: tenderness of the coccyx tip, sacrococcygeal joint, paracoccygeal soft tissues.
• Digital rectal examination (DRE): the single most informative manoeuvre. The examiner places the index finger intrarectally and the thumb externally, grasps the coccyx, and assesses (i) tenderness, (ii) passive mobility, (iii) presence of a posterior bony spicule, (iv) hypertonicity of the levator ani and coccygeus muscles. Always obtain informed consent and a chaperone.
• Neurological examination of the lumbosacral roots to exclude radiculopathy.
• Gait and posture assessment.

3.3. Imaging

Technique

• Dynamic radiography (gold standard): lateral views in the standing position and in the patient's habitually painful seated position. The coccygeal mobility angle is measured. Mobility below 5° (immobile) or above 25° (hypermobile) is abnormal. Posterior or anterior coccygeal subluxation can also be quantified.
• MRI of the sacrococcygeal region: indicated for chronic pain > 8 weeks, suspected infection, or atypical features; identifies bony oedema, soft tissue inflammation, occult fracture, sacrococcygeal disc pathology, chordoma, and other neoplasms.
• CT: reserved for evaluation of complex bony anatomy, spicules, or preoperative planning.
• Routine static radiography rarely contributes useful information.

Structured radiological reporting (suggested template)

Technique: Lateral standing and sitting radiographs of the sacrococcygeal region.
Findings: Coccyx composed of [n] segments. Coccygeal mobility angle in transition from standing to sitting: [°]. Presence/absence of anterior or posterior subluxation. Presence/absence of bony spicule at coccyx tip. Sacrococcygeal joint appearance.
Impression: Maigne type [1/2/3/4] coccyx mobility pattern. Correlate clinically; consider [pelvic floor assessment / MRI / injection therapy / surgical evaluation] as indicated.

4. Differential Diagnosis and Red Flags

4.1. Differential diagnosis

• Pilonidal disease, perirectal or pilonidal abscess.
• Sacrococcygeal chordoma, teratoma, metastatic disease.
• Sacral insufficiency fracture (osteoporotic patients).
• Lumbosacral radiculopathy (S3–S5 distribution).
• Pudendal neuralgia, sacroiliac joint dysfunction.
• Endometriosis with rectovaginal involvement.
• Levator ani syndrome, proctalgia fugax.
• Anorectal pathology (fissure, abscess, fistula).

4.2. Red flags requiring urgent imaging and specialist referral

• Pain unrelieved by position change, present at night or at rest.
• Constitutional symptoms: fever, unintentional weight loss, night sweats.
• Progressive neurological deficit, saddle anaesthesia, bowel/bladder dysfunction.
• Palpable mass on DRE or external examination.
• History of malignancy.
• Recent trauma with persistent severe pain and inability to sit at all.

Any red flag mandates MRI of the sacrococcygeal region and, where indicated, oncological, infectious disease, or neurosurgical consultation.

5. Stage 1 — Ergonomic and Pharmacological Management

5.1. Ergonomic modifications (first-line for all patients)

• Wedge or U-shaped cushion (with central or posterior cut-out that offloads the coccyx). Standard donut cushions are generally less effective and may shift load anteriorly.
• Forward-leaning sitting posture: shifts load to the ischial tuberosities and away from the coccyx.
• Activity pacing: stand and ambulate every 20–30 minutes during prolonged sitting.
• Bowel regimen: ensure regular soft stools (adequate fluid intake, fiber 25–30 g/day, lactulose or PEG if needed). Constipation reliably exacerbates coccygodynia.
• Weight management: in patients with BMI > 27, weight reduction is associated with symptom improvement (Maigne, 2000).

5.2. Pharmacotherapy

NSAIDs (first-line analgesia)

• Ibuprofen 400 mg per os every 8 hours for 7–10 days, taken with food.
• Naproxen 250–500 mg per os twice daily for 7–14 days.
• Diclofenac 50 mg per os three times daily, or modified-release 75 mg twice daily for 7–14 days.
• Gastroprotection: co-prescribe omeprazole 20 mg per os once daily in patients with GI risk factors (age > 65, history of peptic ulcer, concurrent antiplatelet or corticosteroid, anticoagulant therapy).
• Contraindications: active peptic ulcer, CKD with eGFR < 30, decompensated heart failure, third-trimester pregnancy, severe hepatic impairment.

Adjunct analgesia

• Paracetamol 1 g per os four times daily — first-line in patients with NSAID contraindications, or as a baseline adjunct.
• Topical NSAID (diclofenac gel 1–2%) has limited rationale in coccygodynia because the coccyx is deep to a thick fat pad; it may be useful only when there is concurrent superficial paracoccygeal soft-tissue tenderness.

Muscle relaxants (selected cases)

• Tizanidine 2–4 mg per os at night, titrated to a maximum of 12 mg/day in divided doses — useful where pelvic floor hypertonicity is prominent. Monitor liver function and blood pressure.

6. Stage 2 — Physiotherapy Protocol

6.1. Initial phase: pain reduction and mobility restoration (weeks 1–4)

Manual therapy

• Intrarectal coccygeal mobilization (Maigne / Thiele technique): performed by a trained physiotherapist. Indicated for type 1–3 coccyx (mobility abnormality, subluxation). 1 session per week for 3–4 weeks. Always with informed consent and a chaperone.
• Levator ani / coccygeus myofascial release: external and intrarectal techniques.

Pelvic floor relaxation

• Diaphragmatic breathing 5 minutes, three times daily.
• Child's pose: hold 30 seconds × 3 repetitions, three times daily.
• Happy baby pose: hold 30 seconds × 3 repetitions.
• Deep squat with heels supported: hold 30 seconds × 5 repetitions daily.
• Cat–cow stretch: 10 repetitions twice daily.

Core stabilization (after acute pain reduction)

• Bridging: 10 repetitions × 2 sets twice daily.
• Modified plank: hold 10–15 s, progressing to 30 s; 2–3 sets daily.

6.2. Strengthening phase (weeks 5–8)

• Transversus abdominis activation (drawing-in manoeuvre): 10 repetitions × 2 sets twice daily.
• Pelvic tilts: 10 repetitions × 2 sets twice daily.
• Side-lying hip abduction: 15 repetitions × 2 sets per side daily.
• Resistance-band hip abduction: 10 repetitions × 2 sets daily.
• Postural retraining: ergonomic education for sitting, lifting, and sleep position.

6.3. Progression criteria

• NRS pain score reduction ≥ 50%.
• Tolerance of sitting for ≥ 30 minutes with cushion.
• Return to work / occupational duties.
• Absence of acute flare in the preceding 2 weeks.

7. Stage 3 — Neuropathic Pain Management

For patients with burning, shooting, electrical, or allodynic pain — indicating a neuropathic component (often ganglion impar–mediated or post-traumatic):

7.1. Amitriptyline

• Starting dose: 10 mg per os at night (5 mg in elderly or frail patients).
• Titration: increase by 10 mg every 5–7 days based on tolerance.
• Target dose: 25–75 mg at night.
• Maximum dose: 100 mg at night, rarely required.
• Duration of trial: minimum 6–8 weeks at the optimally tolerated dose.
• Pre-treatment screening: ECG in patients > 40 years or with cardiovascular risk; assess for prostate enlargement, narrow-angle glaucoma, urinary retention.
• Contraindications: recent myocardial infarction, second/third-degree heart block, QT prolongation, concurrent MAOI use, severe hepatic impairment, mania.
• Common adverse effects: dry mouth, sedation, weight gain, constipation (caution — may worsen coccygodynia), orthostatic hypotension.

7.2. Gabapentin

• Starting dose: 300 mg per os at night (100 mg in elderly).
• Titration: 300 mg every 2–3 days, dividing into 2–3 daily doses.
• Target dose: 900–1800 mg/day in three divided doses.
• Maximum dose: 3600 mg/day.
• Renal dose adjustment (essential): CrCl 30–59 → 400–1400 mg/day; CrCl 15–29 → 200–700 mg/day; CrCl < 15 → 100–300 mg/day.
• Adverse effects: somnolence, dizziness, peripheral oedema, weight gain, ataxia.
• Caution: dependence and misuse potential is now recognized; avoid abrupt withdrawal.

7.3. Alternatives

• Pregabalin 75 mg twice daily, titrated to 150–300 mg twice daily; faster onset than gabapentin, similar adverse effect profile, renal dose adjustment required.
• Duloxetine 30 mg per os once daily for 1 week, then 60 mg once daily; SNRI with evidence in chronic musculoskeletal pain. Avoid in uncontrolled glaucoma, severe hepatic impairment, MAOI use.

8. Stage 4 — Interventional Procedures

8.1. Local corticosteroid injection

• Indications: persistent pain after 4–6 weeks of conservative management; localized tenderness at the sacrococcygeal joint or coccyx tip.
• Technique: triamcinolone acetonide 40 mg (or methylprednisolone 40–80 mg) mixed with 4–5 mL of 1% lidocaine, infiltrated around the sacrococcygeal joint and tender areas under ultrasound or fluoroscopic guidance.
• Frequency: response assessment at 2–4 weeks. May repeat at 6–8 weeks if partial benefit. Maximum 2–3 injections per year due to local tissue atrophy and fat pad weakening.
• Expected outcome: 60–70% of patients report meaningful relief, often lasting weeks to several months.

8.2. Ganglion impar block

• Indications: chronic coccygodynia refractory to local injection and conservative management; suspected sympathetically maintained pain.
• Technique: trans-sacrococcygeal approach under fluoroscopic guidance is most common. A spinal needle is advanced through the sacrococcygeal ligament; 4–6 mL of 0.25% bupivacaine ± 40 mg triamcinolone is injected anterior to the sacrococcygeal junction.
• Expected outcome: 70–80% of selected patients achieve significant relief; mean duration 2–6 months.
• Complications (rare): rectal perforation, infection, bleeding, transient bowel/bladder dysfunction.

8.3. Pulsed radiofrequency ablation of the ganglion impar

• Indications: positive but short-lived response to ganglion impar block.
• Technique: pulsed radiofrequency at 42 °C × 240 s applied to the ganglion impar via trans-sacrococcygeal approach.
• Expected outcome: relief duration 6–12 months in 60–75% of responders; neurolytic effect is non-destructive, minimizing risk of motor or sphincter dysfunction.

8.4. Extracorporeal shock wave therapy (ESWT)

• Indications: chronic coccygodynia unresponsive to conservative measures, particularly with sacrococcygeal soft-tissue tenderness.
• Protocol: 2000–3000 impulses per session at 0.10–0.20 mJ/mm², once weekly for 4 sessions.
• Evidence: small randomized trials and case series suggest meaningful short-term pain reduction; long-term data limited.
• Contraindications: pregnancy, coagulopathy, local infection, malignancy in the field.

9. Stage 5 — Surgical Management (Coccygectomy)

9.1. Indications

• Failure of ≥ 6 months of structured conservative and interventional management.
• Confirmed structural pathology on dynamic imaging (Maigne type 1, 2, or 4 with spicule).
• Documented positive response to local anesthetic injection — a critical predictor of surgical success.
• Significant functional impairment and reduced quality of life.

9.2. Procedure

• Partial or total coccygectomy via a midline posterior approach with the patient prone (jack-knife position).
• Subperiosteal dissection, preservation of the anococcygeal ligament insertion when feasible, careful haemostasis, layered closure.
• Preoperative bowel preparation; perioperative antibiotic prophylaxis (first-generation cephalosporin) to reduce wound infection risk.

9.3. Outcomes and complications

• Success rate: 70–90% of carefully selected patients report substantial improvement at 1–2 years (Trollegaard et al. 2010; Karadimas et al. 2011).
• Wound infection: 5–22% (highest among orthopedic procedures due to perineal location). Mitigated by meticulous technique, prophylactic antibiotics, and bowel preparation.
• Wound dehiscence, persistent pain, sacrococcygeal instability, dyspareunia (rare).

9.4. Postoperative care

• Multimodal analgesia (paracetamol + NSAID where permitted ± short course of opioid).
• Wound care with daily inspection; clear instructions on hygiene after bowel movement.
• Lateral or prone resting positions for the first 2 weeks; cushion-supported sitting from week 3.
• Structured physiotherapy from week 6 (pelvic floor relaxation, core stabilization, gait retraining).
• Expected return to full sitting tolerance and occupational duties: 8–12 weeks.

10. Special Populations

10.1. Postpartum coccygodynia

Affects up to 20% of women after vaginal delivery, with higher risk after instrumental delivery, prolonged second stage, and macrosomia. Pathophysiology: forced hyperextension or fracture of the coccyx. Most cases resolve spontaneously within 6–8 weeks. Management: cushion, paracetamol (compatible with breastfeeding), ibuprofen (compatible after the immediate postpartum period), pelvic floor physiotherapy. Avoid amitriptyline during breastfeeding where possible. Persistent pain beyond 8 weeks warrants dynamic radiography.

10.2. Adolescent and pediatric patients

Coccygodynia is uncommon in children. Persistent coccygeal pain in a child or adolescent mandates MRI to exclude sacrococcygeal teratoma, Ewing sarcoma, or other pathology before symptomatic treatment.

10.3. Elderly patients

Consider sacral insufficiency fracture in osteoporotic patients. NSAID risk increases substantially with age (renal, GI, cardiovascular); favor paracetamol, topical agents, and physiotherapy. Reduce starting doses of amitriptyline and gabapentin.

11. Follow-Up and Escalation Criteria

Time point	Assessment	Escalation criterion
2 weeks	NRS pain, function, sitting tolerance, medication tolerance	No improvement → reinforce ergonomics; consider physiotherapy initiation if not already
4–6 weeks	Response to NSAID + physiotherapy	< 30% improvement → dynamic radiography (if not done); consider local corticosteroid injection
3 months	Outcome of injection ± neuropathic agents	Persistent disability → ganglion impar block; MRI if not done
6 months	Comprehensive reassessment	Treatment-refractory → multidisciplinary review; consider pulsed RF or surgical evaluation
12 months	Post-surgical or chronic management review	Persistent symptoms despite optimal management → pain medicine specialist

Clinical pearls.

• Dynamic radiography is the single most useful imaging study and is underused in primary practice.
• A positive response to local anesthetic injection is the strongest predictor of surgical success — never proceed to coccygectomy without it.
• Pelvic floor dysfunction is an under-recognized cause of "idiopathic" coccygodynia and should be specifically assessed by DRE and skilled physiotherapy evaluation.
• Treat constipation aggressively — it is both a precipitant and a perpetuator.
• Coccygodynia persisting > 8 weeks in a child or with red flags is not coccygodynia until proven otherwise.

12. Conclusion

Coccygodynia is a well-defined clinical entity that responds to a structured stepwise management strategy in the majority of patients. Accurate diagnosis through dynamic radiography and rectal examination, Maigne-based classification, and a clearly tiered treatment ladder — from ergonomics and NSAIDs through physiotherapy, neuropathic agents, injections, and, when justified, coccygectomy — provides durable symptom control while minimizing the risk of unnecessary procedures. Multidisciplinary collaboration between orthopedics, pelvic physiotherapy, pain medicine, and radiology yields the best long-term outcomes.

References

1. Lirette LS, Chaiban G, Tolba R, Eissa H. Coccydynia: an overview of the anatomy, etiology, and treatment of coccyx pain. Ochsner J. 2014;14(1):84–87. PMC
2. Maigne JY, Doursounian L, Chatellier G. Causes and mechanisms of common coccydynia: role of body mass index and coccygeal trauma. Spine. 2000;25(23):3072–3079. PubMed
3. Foye PM. Coccydynia: tailbone pain. Phys Med Rehabil Clin N Am. 2017;28(3):539–549. PubMed
4. Trollegaard AM, Aarby NS, Hellberg S. Coccygectomy: an effective treatment option for chronic coccydynia. J Bone Joint Surg Br. 2010;92(2):242–245. PubMed
5. Howard PD, Dolan AN, Falco AN, et al. A comparison of conservative interventions and their effectiveness for coccydynia. J Man Manip Ther. 2013;21(4):213–219. PMC
6. Patel R, Appannagari A, Whang PG. Coccydynia. Curr Rev Musculoskelet Med. 2008;1(3-4):223–226. PMC
7. Karadimas EJ, Trypsiannis G, Giannoudis PV. Surgical treatment of coccygodynia: an analytic review of the literature. Eur Spine J. 2011;20(5):698–705.
8. Gonnade N, Mehta N, Khera PS, et al. Ganglion impar block in patients with chronic coccydynia. Indian J Radiol Imaging. 2017;27(3):324–328.
9. Maigne JY, Chatellier G, Faou ML, Archambeau M. The treatment of chronic coccydynia with intrarectal manipulation: a randomized controlled study. Spine. 2006;31(18):E621–E627.
10. BMJ Best Practice. Coccydynia. bestpractice.bmj.com
11. StatPearls. Coccyx Pain. NCBI Bookshelf

Disclaimer. This material is intended for educational purposes for medical professionals. It does not replace clinical judgment, does not constitute personal medical advice, and must not be used by patients for self-medication. All decisions regarding the use of medications, procedures, and surgery must be made by physicians on an individual basis, taking into account the clinical situation, comorbidities, concurrent medications, and applicable legislation.

Prepared by Dr. Vasyl Shlemko, orthopedic and trauma surgeon. Document version: May 2026.